Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585962 · ClinicalTrials.gov registry record · Phase 2
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
NCT00585962: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT00585962 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585962, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if high doses of radiation using proton beam can be given safely with low and acceptable side effects. This study will also gather data to determine the ability of the proton beam to eradicate prostate cancer. Proton beam radiation is a very accurate kind of treatment that has been shown to affect less normal tissue than a regular radiation beam.
Interventions
- RADIATION Proton Beam Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2004-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585962
The ClinicalTrials.gov registry entry for NCT00585962 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Beam Radiation is the first listed.
NCT00585962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585962 about?
NCT00585962 is a clinical study titled "Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate". The primary purpose of this study is to determine if high doses of radiation using proton beam can be given safely with low and acceptable side effects. This study will also gather data to determine the ability of the proton beam to eradicate prostate cancer. Proton beam radiation is a very accurate...
What is the current status of trial NCT00585962?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2004-02.
What interventions are being tested in trial NCT00585962?
The interventions under investigation include: Proton Beam Radiation (RADIATION).
Who is sponsoring clinical trial NCT00585962?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.